S&P 500   3,321.75 (+0.03%)
DOW   29,186.27 (-0.03%)
QQQ   223.87 (+0.26%)
AAPL   317.70 (+0.36%)
FB   221.32 (-0.05%)
MSFT   165.70 (-0.48%)
AMZN   1,887.46 (-0.24%)
NVDA   250.05 (+0.85%)
BABA   222.37 (+0.05%)
GE   11.37 (-2.49%)
TSLA   569.56 (+4.09%)
AMD   51.43 (+0.74%)
T   39.04 (+1.35%)
PRI   126.65 (+0.19%)
BAC   34.36 (+0.29%)
GILD   63.43 (+1.28%)
S&P 500   3,321.75 (+0.03%)
DOW   29,186.27 (-0.03%)
QQQ   223.87 (+0.26%)
AAPL   317.70 (+0.36%)
FB   221.32 (-0.05%)
MSFT   165.70 (-0.48%)
AMZN   1,887.46 (-0.24%)
NVDA   250.05 (+0.85%)
BABA   222.37 (+0.05%)
GE   11.37 (-2.49%)
TSLA   569.56 (+4.09%)
AMD   51.43 (+0.74%)
T   39.04 (+1.35%)
PRI   126.65 (+0.19%)
BAC   34.36 (+0.29%)
GILD   63.43 (+1.28%)
S&P 500   3,321.75 (+0.03%)
DOW   29,186.27 (-0.03%)
QQQ   223.87 (+0.26%)
AAPL   317.70 (+0.36%)
FB   221.32 (-0.05%)
MSFT   165.70 (-0.48%)
AMZN   1,887.46 (-0.24%)
NVDA   250.05 (+0.85%)
BABA   222.37 (+0.05%)
GE   11.37 (-2.49%)
TSLA   569.56 (+4.09%)
AMD   51.43 (+0.74%)
T   39.04 (+1.35%)
PRI   126.65 (+0.19%)
BAC   34.36 (+0.29%)
GILD   63.43 (+1.28%)
S&P 500   3,321.75 (+0.03%)
DOW   29,186.27 (-0.03%)
QQQ   223.87 (+0.26%)
AAPL   317.70 (+0.36%)
FB   221.32 (-0.05%)
MSFT   165.70 (-0.48%)
AMZN   1,887.46 (-0.24%)
NVDA   250.05 (+0.85%)
BABA   222.37 (+0.05%)
GE   11.37 (-2.49%)
TSLA   569.56 (+4.09%)
AMD   51.43 (+0.74%)
T   39.04 (+1.35%)
PRI   126.65 (+0.19%)
BAC   34.36 (+0.29%)
GILD   63.43 (+1.28%)
Log in

NYSE:MCK - McKesson Stock Price, Forecast & News

$155.80
+0.53 (+0.34 %)
(As of 01/22/2020 04:00 PM ET)
Today's Range
$154.54
Now: $155.80
$156.45
50-Day Range
$135.37
MA: $142.45
$156.33
52-Week Range
$110.52
Now: $155.80
$156.97
Volume943,945 shs
Average Volume821,998 shs
Market Capitalization$28.07 billion
P/E RatioN/A
Dividend Yield1.05%
Beta1.12
McKesson Corporation provides pharmaceuticals and medical supplies in the United States and internationally. It operates in three segments: U.S. Pharmaceutical and Specialty Solutions, European Pharmaceutical Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs, as well as other healthcare-related products; and offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices. Read More…

Industry, Sector and Symbol

Industry Drugs, proprietaries, & sundries
Sub-IndustryHealth Care Distributors
SectorMedical
CUSIP58155Q10
Phone972-446-4800

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$214.32 billion
Cash Flow$29.62 per share
Book Value$43.20 per share

Profitability

Net Income$34 million

Miscellaneous

Employees80,000
Market Cap$28.07 billion
Next Earnings Date2/4/2020 (Confirmed)
OptionableOptionable

Receive MCK News and Ratings via Email

Sign-up to receive the latest news and ratings for MCK and its competitors with MarketBeat's FREE daily newsletter.


McKesson (NYSE:MCK) Frequently Asked Questions

What is McKesson's stock symbol?

McKesson trades on the New York Stock Exchange (NYSE) under the ticker symbol "MCK."

How often does McKesson pay dividends? What is the dividend yield for McKesson?

McKesson declared a quarterly dividend on Wednesday, October 23rd. Investors of record on Monday, December 2nd will be given a dividend of $0.41 per share on Thursday, January 2nd. This represents a $1.64 dividend on an annualized basis and a yield of 1.05%. The ex-dividend date of this dividend is Friday, November 29th. View McKesson's Dividend History.

How were McKesson's earnings last quarter?

McKesson Co. (NYSE:MCK) announced its quarterly earnings results on Wednesday, October, 30th. The company reported $3.60 EPS for the quarter, meeting the Thomson Reuters' consensus estimate of $3.60. The business had revenue of $57.62 billion for the quarter, compared to the consensus estimate of $55.06 billion. McKesson had a positive return on equity of 32.77% and a negative net margin of 0.29%. The firm's revenue was up 8.6% on a year-over-year basis. During the same period last year, the firm posted $3.60 earnings per share. View McKesson's Earnings History.

When is McKesson's next earnings date?

McKesson is scheduled to release their next quarterly earnings announcement on Tuesday, February 4th 2020. View Earnings Estimates for McKesson.

How can I listen to McKesson's earnings call?

McKesson will be holding an earnings conference call on Tuesday, February 4th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

What guidance has McKesson issued on next quarter's earnings?

McKesson updated its FY20 earnings guidance on Monday, January, 13th. The company provided earnings per share (EPS) guidance of $14.60-14.80 for the period, compared to the Thomson Reuters consensus estimate of $14.38.

What price target have analysts set for MCK?

10 Wall Street analysts have issued 1-year price targets for McKesson's stock. Their forecasts range from $140.00 to $170.00. On average, they anticipate McKesson's stock price to reach $154.78 in the next year. This suggests that the stock has a possible downside of 0.9%. View Analyst Price Targets for McKesson.

What is the consensus analysts' recommendation for McKesson?

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for McKesson in the last year. There are currently 1 sell rating, 6 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for McKesson.

Has McKesson been receiving favorable news coverage?

News coverage about MCK stock has been trending somewhat positive recently, according to InfoTrie Sentiment. The research group scores the sentiment of news coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. McKesson earned a daily sentiment score of 2.0 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the stock's share price in the immediate future. View News Stories for McKesson.

Are investors shorting McKesson?

McKesson saw a decline in short interest in December. As of December 13th, there was short interest totalling 3,670,000 shares, a decline of 13.2% from the November 28th total of 4,230,000 shares. Based on an average trading volume of 1,610,000 shares, the days-to-cover ratio is presently 2.3 days. Approximately 2.0% of the shares of the stock are short sold. View McKesson's Current Options Chain.

Who are some of McKesson's key competitors?

What other stocks do shareholders of McKesson own?

Based on aggregate information from My MarketBeat watchlists, some companies that other McKesson investors own include Walt Disney (DIS), Gilead Sciences (GILD), Allergan (AGN), CVS Health (CVS), UnitedHealth Group (UNH), Johnson & Johnson (JNJ), AbbVie (ABBV), Boeing (BA), salesforce.com (CRM) and NVIDIA (NVDA).

Who are McKesson's key executives?

McKesson's management team includes the folowing people:
  • Mr. John H. Hammergren, Chairman & CEO (Age 60)
  • Britt J. Vitalone, CFO & Exec. VP (Age 50)
  • Ms. Lori A. Schechter, Chief Compliance Officer, Exec. VP & Gen. Counsel (Age 57)
  • Mr. Jorge L. Figueredo, Exec. VP & Chief HR Officer (Age 58)
  • Mr. Bansi Nagji, Exec. VP and Chief Strategy & Bus. Devel. Officer (Age 54)

Who are McKesson's major shareholders?

McKesson's stock is owned by a variety of of institutional and retail investors. Top institutional investors include PGGM Investments (0.17%), Wedge Capital Management L L P NC (0.16%), Zurcher Kantonalbank Zurich Cantonalbank (0.07%), Nisa Investment Advisors LLC (0.05%), Calamos Advisors LLC (0.03%) and CLARET ASSET MANAGEMENT Corp (0.03%). Company insiders that own McKesson stock include Brian S Tyler, Brian Scott Tyler, Britt J Vitalone, Erin M Lampert, Lori A Schechter, M Christine Jacobs, N Anthony Coles and Sundeep G Reddy. View Institutional Ownership Trends for McKesson.

Which major investors are selling McKesson stock?

MCK stock was sold by a variety of institutional investors in the last quarter, including PGGM Investments, Assenagon Asset Management S.A., Artemis Investment Management LLP, Kempner Capital Management Inc., Meag Munich Ergo Kapitalanlagegesellschaft MBH, Nisa Investment Advisors LLC, Calamos Advisors LLC and State of Alaska Department of Revenue. Company insiders that have sold McKesson company stock in the last year include Brian S Tyler, Brian Scott Tyler, Britt J Vitalone, Lori A Schechter, M Christine Jacobs and Sundeep G Reddy. View Insider Buying and Selling for McKesson.

Which major investors are buying McKesson stock?

MCK stock was acquired by a variety of institutional investors in the last quarter, including Wedge Capital Management L L P NC, Contravisory Investment Management Inc., DNB Asset Management AS, Zurcher Kantonalbank Zurich Cantonalbank , Janney Montgomery Scott LLC, Inlet Private Wealth LLC, Alpine Global Management LLC and Ullmann Financial Group Inc.. View Insider Buying and Selling for McKesson.

How do I buy shares of McKesson?

Shares of MCK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is McKesson's stock price today?

One share of MCK stock can currently be purchased for approximately $156.18.

How big of a company is McKesson?

McKesson has a market capitalization of $28.14 billion and generates $214.32 billion in revenue each year. The company earns $34 million in net income (profit) each year or $13.57 on an earnings per share basis. McKesson employs 80,000 workers across the globe.View Additional Information About McKesson.

What is McKesson's official website?

The official website for McKesson is http://www.mckesson.com/.

How can I contact McKesson?

McKesson's mailing address is 6555 STATE HWY 161, IRVING TX, 75039. The company can be reached via phone at 972-446-4800 or via email at [email protected]


MarketBeat Community Rating for McKesson (NYSE MCK)

Community Ranking:  3.1 out of 5 (star star star)
Outperform Votes:  833 (Vote Outperform)
Underperform Votes:  510 (Vote Underperform)
Total Votes:  1,343
MarketBeat's community ratings are surveys of what our community members think about McKesson and other stocks. Vote "Outperform" if you believe MCK will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MCK will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/22/2020 by MarketBeat.com Staff

Featured Article: Commodities

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel